<DOC>
	<DOCNO>NCT01034865</DOCNO>
	<brief_summary>To identify risk factor development diagnosis hepatocellular CA patient chronic hepatitis C use data ultimately develop effective screening program .</brief_summary>
	<brief_title>Risk Factors Molecular Genomics U.S . Patients With Chronic Liver Disease &amp; Hepatocellular CA</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>*For experimental subject control : 1 . Patients older 18 year age ethnic background gender . 2 . Patients chronic liver disease For Experimental Subjects Only : 1 . Patients HCC either : ( ) hepatic mass large equal 5cm , ; ( ii ) hepatic mass lesion confirm fine needle aspirate ( FNA ) pathology case surgical resection , ; ( iii ) hepatic mass lesion characteristic CT MRI angiographic appearance . For Controls Only : Patients chronic liver disease without evidence HCC confirm either : 1. normal AFP level 2. negative imaging study ( ultrasound , CT , MR image ) . 3 . Negative liver cancer explants . 1 . Patients decline participate study 2 . Patients history HIV infection 3 . Patients concurrent advanced malignancy nonhepatic origin . 4 . Patients significant use androgenic steroid . 5 . Patients exposure vinyl chloride .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>